Ravi Retnakaran MD MSc FRCPC and Haysook Choi, Author at Diabetes Care Community

Ravi Retnakaran MD MSc FRCPC and Haysook Choi

Dr. Ravi Retnakaran is a Professor of Medicine at the University of Toronto and an endocrinologist and clinician-scientist at Mount Sinai Hospital in Toronto, Canada. His research program focuses on the pathophysiology and treatment of type 2 diabetes (T2DM), with a particular interest in the potential reversibility of pancreatic beta-cell dysfunction early in the course of diabetes. In this context, his research group is conducting a series of innovative clinical trials evaluating novel therapeutic strategies for the preservation of beta-cell function in early T2DM, including the CIHR-funded RESET IT Trial and PREVAIL Trial. Haysook Choi is a Registered Nurse and Certified Diabetes Educator with over 25 years of experience in the field of diabetes management. She is presently working as a clinical research nurse coordinator at the Leadership Sinai Centre for Diabetes in Toronto. Currently her focus is on the RESET IT trial that is evaluating novel strategies for preservation of beta-cell function and thereby maintaining remission of Type 2 Diabetes.

Clinical trials to stop the progression of type 2 diabetes

Ravi Retnakaran MD MSc FRCPC and Haysook Choi June 26, 2017 Diabetes Overview Articles, Type 2 diabetes

Can the progression of diabetes be stopped? Researchers at Mount Sinai Hospital in Toronto are conducting two studies to see if this might be the case.